CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Intracranial Aneurysms - Market Insights, Competitive Landscape, and Market Forecast - 2030
... America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing cases of chronic disorders and the rising product developmental activities worldwide The ... Read More
-
Deep Brain Stimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Epilepsy, Obsessive Compulsive Disorder, Dystonia, and Others), End-User (Hospitals and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing ... Read More
-
Major Depressive Disorder Market Assessment, By Drug Classes [Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Others], By Distribution Channel [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies], By Region, Opportunities and Forecast, 2017-2031F
... United States radiotherapy devices market is projected to witness a CAGR of 8.70% during the forecast period 2024-2031, growing from USD 2.56 billion in 2023 to USD 4.99 billion in 2031. The market growth is ... Read More
-
Electrical Stimulation Devices Global Market Opportunities And Strategies To 2033
... Neurological & Movement Disorder Management; Musculoskeletal Disorder Management; Metabolism & Git Management3) By End-User: Hospitals; Ambulatory Surgical Centers Covering: Medtronic plc; Boston Scientific Corporation; Abbott Laboratories; Koninklijke Philips N.V.; Nevro Corp Electrical Stimulation Devices Global ... Read More
-
Antidepressant Market Report: Trends, Forecast and Competitive Analysis to 2030
... and panic disorder markets. The global antidepressant market is expected to reach an estimated $21.8 billion by 2030 with a CAGR of 5.3% from 2024 to 2030. The major drivers for this market are the ... Read More
-
Conventional and Alternative Pain Treatment Markets
... and alternative pain treatments and includes a detailed analysis of the competitive environment. The report covers the drivers, restraints and opportunities in the market; surveys the prevalence of or incidence of chronic diseases; and highlights ... Read More
-
Global Brain Tumor Diagnostics Market 2024-2028
... period. The report on the brain tumor diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Cell and Gene Therapy Market Research Report Information by Therapy Type (Cell Therapy and Gene Therapy), Application (Cancer, Neurological Disorders, Cardiovascular Disorders, Rare Diseases, Ophthalmology, Blood Disorders and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... and Rest of the World) Industry Forecast till 2032 In 2023, the e-Visa market was estimated to be worth USD 933.4 million. With a compound annual growth rate (CAGR) of 11.1% from 2024 to 2032, ... Read More
-
Schizophrenia - Pipeline Insight, 2024
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Schizophrenia: Understanding Schizophrenia: ... Read More
-
Brain Computer Interface
... by 2030, growing at a CAGR of 10.3% over the analysis period 2023-2030. Invasive BCI, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.5 Billion by ... Read More
-
Acute Repetitive Seizures
... by 2030, growing at a CAGR of 44.7% over the analysis period 2023-2030. Diastat Rectal Gel, one of the segments analyzed in the report, is expected to record a 46.2% CAGR and reach US$8.4 Billion ... Read More
-
Neuroprotection Therapeutics
... at a CAGR of 6.9% over the analysis period 2023-2030. Free Radical Trapping Agents (Antioxidants), one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$45.7 Billion by ... Read More
-
Lou Gehrig’s disease - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Glioblastoma Multiforme Treatment (GBM)
... reach US$4.8 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Radiation Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach ... Read More
-
Connected Care in North America 3rd Edition
... and remote patient monitoring (RPM) markets in thisregion. This strategic research report from Berg Insight providesyou with 150 pages of unique business intelligence including 5-yearindustry forecasts and expert commentary on which to base yourbusiness decisions. Read More
-
Biosimulation Market by Offering (Module, Integrated Platform), Application (Disease Modeling, PBPK, PKPD, Trial Simulation, Manufacturing & Supply chain: planning & forecasting), Indication (Cancer, CNS, CVS), End User, & Region - Global Forecast to 2029
... biosimulation market is projected to reach USD 9.18 billion by 2029 from USD 4.24 billion in 2024, at a CAGR of 16.7% from 2024 to 2029. Increasing need for cost and time reduction in the ... Read More
-
Vertigo - Global Clinical Trials Review, 2024
... the clinical trials on Vertigo. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 ... Read More
-
Brain-Computer Interface: Global Markets
... from 2024 through 2029. Revenue forecasts for this period are segmented by component, technology, type, application and geographical region. The report covers the emerging technologies that are expected to shape the BCI market in the ... Read More
-
Global Glioblastoma Multiforme Treatment Market 2024-2028
... period. The report on the glioblastoma multiforme treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Global Ambulatory Infusion Center Market 2024-2028
... infusion center market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
2024 Diseases of the Nervous System Global Market Size & Growth Report with Updated Analysis & Forecasts
... growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2012 through 2023, with forecasts for 2024 and 2028. The ... Read More
-
Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound), Therapeutic Area (Infectious, Oncology, CNS, CVD), End User (Pharma, Biotech, CROs) - Global Forecast to 2029
... to projections, the global clinical trial imaging market is expected to grow at a compound annual growth rate (CAGR) of 7.8%, from USD 1.42 billion in 2024 to USD 2.07 billion by 2029. Factors driving ... Read More
-
Opioids
... of 2.3% over the analysis period 2023-2030. Extended-Release / Long-Acting Opioids, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$18.7 Billion by the end of the ... Read More
-
Cognitive Assessment and Training
... reach US$31.0 Billion by 2030, growing at a CAGR of 27.1% over the analysis period 2023-2030. Solutions Component, one of the segments analyzed in the report, is expected to record a 25.1% CAGR and reach ... Read More
-
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases
... US$9.1 Billion in the year 2023, is expected to reach US$16.4 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.5 Billion While China ... Read More
Research Assistance
